ArticleIranian journal of pharmaceutical research : IJPR2022
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial.
Ilad Alavi-Darazam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.